Forgot your password?
New User?
Remember me
banner banner

You are here:Home » Molecular Biology » MB-Protease Inhibitors » Bacillus anthracis Lethal Factor Protease Inhibitor-1 (LFPI), Recombinant (Anthrax)

Bacillus anthracis Lethal Factor Protease Inhibitor-1 (LFPI), Recombinant (Anthrax)


  For pricing information, USA customers sign in.
  Outside USA? Please contact your distributor for pricing.


Bacillus anthracis Lethal factor, protease Inhibitor-1, Cell permeable, 14aa MEK2 analog, competitive inhibitor of LF
Catalog #B0003-09
Sequence (linear) Ac-Gly-Tyr-beta-Ala-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Val-Leu-Arg-NHOH
Mol. Wt: 1984.5
After inhalation by mammals, Bacillus anthracis spores germinate in alveolar macrophages then migrate to lymph nodes where they multiply. The vegetative bacteria excrete the tripartite exotoxin which consists of three polypeptides protective antigen (PA, 83kD), lethal factor (LF, 90kD) and oedma factor (OF, 89kD). The two components (OF and LF) of the toxin enzymatically modify substrates within the cytosol of the mammalian cells: The OF is an adenylate cyclase that impairs the host defenses through a variety of mechanisms inhibiting phagocytosis. The LF is a zinc dependent protease that cleaves several mitogen activated protein kinase kinases (MAPKK) and causes lysis of macrophages. To intoxicate mammalian cells, the third component of the toxin PA, binds to a ubiquitously expressed cellular receptor, Tumor Endothelium Marker-8 (TEM8). Upon binding to TEM8, PA is cleaved into 20 and 63kDa fragments (PA20 and PA63) by furin or furin-like proteases. PA20 dissociates into medium and allows the PA63 fragment to heptamerize and bind LF and OF of the toxin. The resulting complex of PA63 fragment with EF and/or OF binds to PA-receptor TEM8/ATR and internalized into endosomes followed by translocation of LF and OF into cytosol of the cells.
Anthrax lethal toxin produced by the bacterium Bacillus anthracis is the major cause of death in animals infected with anthrax.One component of this toxin, lethal factor (LF), inactivates membersof the mitogen-activated protein kinase kinase or MEK family throughproteolysis of their NH2 termini. Although LF has been shown to cleave the NH2 termini of select members of the mitogen-activated protein kinase kinase or MEKfamily, the substrate requirements that determine LF specificityare unknown. Indirect evidence suggests that epitopes distal to the cleavage site are required for LF-MEK interaction.
B. anthracis Lethal Factor (LF) is comprised of four domains domain I binds the protective antigen to enter the target cell, domain II, III and IV create a long groove to hold and cleave the MAPKK proteins heptamer to insert into the membrane and form a water filled channel.
Storage and StabilityLyophilized powder may be stored at 4°C for short-term only. Stable for 12 months at -20°C. Reconstitute to nominal volume (see reconstitution instructions for peptides) and store at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.
Molecular Weight1984.5
Purity97% by HPLC.
FormSupplied as a trifluoroacetate salt.Solubility: DMSO
SpecificityLFPI-4 is a cell-permeable N-acetylated, C-hydroxamate derivative of a 14-mer peptide designed from the MEK-2 template that acts as a competitive inhibitor of Anthrax lethal factor (LF) metalloprotease (Ki = 1 nM). Also inhibits MEK-3 cleavage. Protects against Anthrax toxin induced cytotoxicity in RAW264.7 and J772.A1 cells..
Important NoteThis product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.

External Links